Acuity Functional Impact and Implementation Outcomes Evaluation

This study will test feature enhancements to a behavioral therapy data collection software (Motivity) that will add a new clinical decision support module, called Acuity. Acuity is a Quality Improvement (QI) intervention targeted at Behavior Analysts (BAs) and Behavior Technicians (BTs) that aims to improve the delivery of autism behavioral therapy. Subjects will be staff recruited from existing Motivity customers.

Study Overview

• Status: Enrolling by invitation
• Conditions: Autism
• Intervention / Treatment: Behavioral: Acuity

Detailed Description

Acuity is intended to provide significant improvements in treatment planning, progress tracking, trend monitoring, and dosage management. If successful, Acuity will provide Applied Behavior Analysis (ABA) practitioners with a higher level of real-time insight into their clinical data, enabling more efficient and productive treatment. Research has shown that first-generation systems fall short in supporting overworked BAs who are overwhelmed with data. Acuity will address critical shortfalls by enabling more agile corrective actions and data-driven planning across multiple aspects of treatment, providing practitioners with new levels of rigorous, real-time insight into their clinical data. Acuity will help BAs establish and adhere to realistic treatment timelines, and will proactively alert the BA to noteworthy trends in the data as they occur, such as learner performance issues, missed dosages, and significant changes in tracked behaviors. In doing so, Acuity will support more responsive and effective treatment.

• Study Type: Interventional
• Enrollment (Estimated): 102
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Hawaii
    • Honolulu, Hawaii, United States, 96816
      • Experiad LLC

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Behavior Analysts and Behavior Technicians treating kids with autism
• Must be employed by one of the autism treatment clinics that have agreed to participate in the study.
• Must be employed by Experiad customers who are using Motivity software as part of their practice.

Exclusion Criteria:

• All people not listed above

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Acuity-Basic	Behavioral: Acuity; Enhancement to Motivity product for clinical decision support; Other Names: Motivity
Experimental: Acuity-Enhanced	Behavioral: Acuity; Enhancement to Motivity product for clinical decision support; Other Names: Motivity

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of participants with improved estimation of Trials to Criterion and Time (days) to Criterion	Does Acuity make initial timeline estimates for sets of targets more accurate?	through study completion, expected to be 18 months from the start of retroactive observation period
Increased frequency of changes to programs and prescribed dosages, resulting in reduced Trials to Criterion and Time to Criterion.	Does Acuity result in corrective action being taken more quickly for programs that are off schedule or targets that are exhibiting performance issues?	through study completion, expected to be 18 months from the start of retroactive observation period
Increased adherence to prescribed dosage	Does Acuity result in increased adherence to prescribed dosage, as measured by system	through study completion, expected to be 18 months from the start of retroactive observation period
Number of participants who find Acuity and its components practical and possible to use, assessed by qualitative measures and system usage tracking	Feasibility - To what extent are Acuity and its components practical or possible to use?	at the end of the study, expected to be 18 months from the start of retroactive observation period
Proportion of clinics and providers that actively use Acuity, assessed by system usage tracking.	Adoption - What proportion of clinics and providers are willing to use Acuity and how well do they represent the population of clinics and providers?	at the end of the study, expected to be 18 months from the start of retroactive observation period
Number of BAs & BTs who utilize Acuity as intended to provide learners with accurate treatment plans, and achieve expected results, as measured by system usage and qualitative assessment.	Fidelity - the degree to which BAs and BTs use the system as expected, including dosage adherence, treatment planning accuracy, and timely protocol modification.	at the end of the study, expected to be 18 months from the start of retroactive observation period
Majority of BAs and BTs rate Acuity and its components as attractive, agreeable, or palatable.	Acceptability, as measured by SUS score and SUS Items 1, 5, 6 & 8 collected via online survey at the end of O0 & O1 from both arms.	at the end of the study, expected to be 18 months from the start of retroactive observation period
Frequency at which Acuity and its components are rated as suitable, fitting, or proper for achieving the goals set forth in treatment plans, as measured by surveys.	Appropriateness - Same measures captured for all primary & secondary research questions in the Functional Impact Evaluation. Brief online survey with Likert scaled items focused on the providers' assessment of how well Acuity and its components are matched to the challenges of planning and executing Treatment Plans.	at the end of the study, expected to be 18 months from the start of retroactive observation period

Collaborators and Investigators

• Sponsor: Experiad LLC

Study record dates

Study Major Dates

• Study Start (Actual): July 18, 2024
• Primary Completion (Estimated): August 31, 2024
• Study Completion (Estimated): July 31, 2025

Study Registration Dates

• First Submitted: August 9, 2024
• First Submitted That Met QC Criteria: August 15, 2024
• First Posted (Actual): August 20, 2024

Study Record Updates

• Last Update Posted (Actual): August 20, 2024
• Last Update Submitted That Met QC Criteria: August 15, 2024
• Last Verified: August 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: Acuity-Study-1

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No